Relative Intelligence · Health Care Distribution

How Cencora (COR) compares with the whole market and its popular alternatives
Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on COR alone. It places COR (Cencora, Inc.) against 16 popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where COR stands in the market, and of the alternatives worth a closer look.
Period covered: COR's full trading record, from April 1995 through September 2026. All returns include reinvested dividends. Data as of October 20, 2026.
Data as of October 20, 2026. Full tables and charts read best on a larger screen.
On this page12 sections
Key findings
- Right nowCOR has outpaced the market, rising 13.1% over the past 3 months against 3.9% for the S&P 500 and 3.2% for the Nasdaq 100. Not every peer went the same way. Over the past 3 months, OPCH (Option Care Health) rose 44.2% and BTSG (BrightSpring Health Services) fell 11.5%. Consistency ↓
- Stock or market?COR's 13.1% gain over the past 3 months far outran its industry: the health care distribution ETF IHF (iShares U.S. Healthcare Providers ETF) rose 7.1%. The S&P 500 rose 3.9%. Its health care distribution peers did not move as one over the past 3 months: OPCH (Option Care Health) rose 44.2%, while BTSG (BrightSpring Health Services) fell 11.5%.
- Past 1 to 3 yearsOver the past year, COR rose 5.7% against 15.8% for the S&P 500 and 17.9% for the Nasdaq 100. The same gap shows up over 3 years (86.5% against 89.3%). By year ↓
- Long termCOR turned $10,000 into $50,600 over the past decade, against $42,100 in the S&P 500. COR's 10-year return of 406% puts it ahead of 81% of the stocks worth at least $300 million with that much history. The S&P 500 returned 321%. Growth of $10,000 ↓
- In a crashCOR fell less than the S&P 500 in five of seven sell-offs, but the late-2018 sell-off broke the pattern: it fell 24.2%, more than the S&P 500's 19.3%. Crash tests ↓
- DiversificationOver 10 years COR kept more of the market's gains than of its losses: 80% of the S&P 500's gains in rising months and 58% of its losses in falling ones, with a beta of 0.56. COR is some diversification, but not a hedge: a correlation of 0.38 with the S&P 500 over 5 years and 0.38 with the total US market, less closely than 54% of stocks worth at least $300 million. Market capture ↓
- Better options
- Popular alternatives
- CAH (Cardinal Health) and MCK (McKesson) earned more than COR over the past 5 years with similar volatility: CAH returned 42.1% a year at 24.7% volatility, against 24.2% a year at 22.8%.
- Nearby categories and themes
- ABBV (AbbVie, pharmaceuticals) was ahead of COR in most short and long periods.
- Whole market
- Few investments have done better on both counts: only one of the 3,633 stocks and funds worth at least $500 million earned more than COR with less volatility over the past 5 years, among them DXJ (WisdomTree Japan Hedged Equity Fund).
How much would $10,000 in COR have grown?
This chart tracks a hypothetical $10,000 investment in COR over the past 29 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of COR over the same span and COR's popular alternatives, among those that traded for the entire period. A second view covers the past 5 years, the period the better options further down the page are judged on. It shows not only where each investment ended up but also how smooth or uneven the path was.
- $10,000 invested in COR at the end of September 1997 would have grown to $574,137 by September 2026, more than the $132,907 it would have become in SPY, an S&P 500 fund.
- Five of the eight other investments on the chart ended ahead of COR, and AAPL finished highest, at $20,534,853.
Choose a period
From the end of September 1997 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 83 of the 1,042 stocks and funds worth at least $500 million that traded the whole period ended ahead of COR; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- AAPL$21M+205,249% total · +30.1% a year
- AMZN$11M+114,749% total · +27.5% a year
- UNH$772,802+7,628% total · +16.2% a year
- WST$660,969+6,510% total · +15.5% a year
- MU$629,766+6,198% total · +15.4% a year
- COR$574,137+5,641% total · +15.0% a year
- LLY$396,376+3,864% total · +13.5% a year
- MCK$208,304+1,983% total · +11.0% a year
- SPY (S&P 500)$132,907+1,229% total · +9.3% a year
- CAH$113,257+1,033% total · +8.7% a year
From the end of September 2021 to the end of September 2026. Hover over a fund in the key to pick out its line. 444 of the 3,628 stocks and funds worth at least $500 million that traded the whole period ended ahead of COR; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- LLY$52,411+424% total · +39.3% a year
- CAH$49,682+397% total · +37.8% a year
- MCK$43,941+339% total · +34.5% a year
- DXJ$32,976+230% total · +27.0% a year
- ABBV$29,134+191% total · +23.8% a year
- COR$26,420+164% total · +21.4% a year
- SPY (S&P 500)$19,000+90.0% total · +13.7% a year
- HCA$18,335+83.3% total · +12.9% a year
- WST$8,848−11.5% total · −2.4% a year
- LFST$8,296−17.0% total · −3.7% a year
COR at a glance
This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout. These figures serve as the baseline for every comparison that follows.
- COR's deepest decline since it began trading in 1995 was 70.9%, from January to December 1999. It took nine months from the low to climb back to its old high.
- Over 29 full calendar years, COR's best was 2000, when it returned 233%, and its worst was 1999, when it lost 53.3%. It lost money in five of those years.
- COR is 7.8% below its all-time high.
The company
- Market value
- $66B
- Industry
- Medical - Distribution
- Price history from
- April 1995
Returns
- Past 1 year
- +5.7%total return
- Past 3 years
- +86.5%+23.1% a year
- Past 5 years
- +195%+24.2% a year
- Past 10 years
- +406%+17.6% a year
- Best calendar year
- +233%2000
- Worst calendar year
- −53.3%1999
- Losing years
- 5 of 29full calendar years
Risk
- Volatility
- 22.8%typical yearly swing, 5 years
- Sharpe ratio
- 1.07return per unit of risk, 5 years
- Worst decline ever
- −70.9%Jan 1999 to Dec 1999
- From its all-time high
- −7.8%below the peak
COR against the whole market
Where COR ranks among every stock and fund, and what across the market has done better.
How does COR rank among all stocks?
This section ranks COR on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history. Where the comparisons with its popular alternatives show how COR stacks up against its peers, these rankings show where it stands in the market as a whole.
- COR's worst decline of the past 10 years ranks in the top 2% of the 2,187 stocks worth at least $300 million, where the top fell the least.
Ranked against U.S.-listed stocks worth at least $300M that have enough history for each measure, so the count changes from row to row; smaller stocks are left out. Lower volatility and smaller declines rank higher.
| Measure | COR | Rank | Standing |
|---|---|---|---|
| 1-year return | +5.7% | 1,751 of 3,287 | bottom 48% |
| 3-year return | +86.5% | 1,053 of 3,017 | top 35% |
| 5-year return | +195% | 328 of 2,893 | top 11% |
| 10-year return | +406% | 412 of 2,202 | top 19% |
| Volatility, 5 years | 22.8% | 196 of 2,893 | top 7% |
| Sharpe ratio, 5 years | 1.07 | 63 of 2,893 | top 2% |
| Worst decline, past 10 years | −32.4% | 38 of 2,187 | top 2% |
What has beaten COR on both return and risk?
Each dot is an investment, placed by how much it earned a year over the past 5 years (higher is better) and how much its price swung, its volatility (further left is calmer). COR sits where the dashed lines cross. Anything in the green box above and to the left earned more than COR with smaller swings, a better trade-off over this period on both counts. Past results are no promise, but a name in the box is worth a closer look.
- One ETF worth at least $500 million sit in the green region: each earned more than COR over the past 5 years with smaller price swings. That is fewer than 1% of the 3,633 screened. Few investments beat it on both counts.
- Among those with at least half COR's swings, DXJ has the best return for its risk: 26.6% a year at 19.1% volatility, 16% less than COR's 22.8%, and a Sharpe ratio (return above cash per unit of volatility) of 1.34 against 1.07 for COR.
Annual return is the annualized total return with dividends reinvested, and volatility the annualized swing in daily prices, both over 5 years. Labeled dots are the strongest picks from the table below and the names called out above, colored by how close they sit to COR. 3,633 stocks and funds worth at least $500 million were screened. Hover over a dot for its figures.
- Popular alternatives
- Same and neighboring categories, and shared themes
- The whole market
Is there a better investment than COR?
Investments that beat COR over the past 5 years on return, volatility, drawdowns, consistency, crash losses or fees, from its popular alternatives out to the whole market.
- Among COR's popular alternatives, CAH and MCK earned more than COR over the past 5 years with similar volatility: CAH returned 42.1% a year at 24.7% volatility, against 24.2% a year at 22.8%.
- Looking beyond its popular alternatives, ABBV (pharmaceuticals) was ahead of COR in most short and long periods.
- Few investments have done better on both counts: only one of the 3,633 stocks and funds worth at least $500 million earned more than COR with less volatility over the past 5 years, among them DXJ.
How this works
The table below lists investments that beat COR over the past 5 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes. It checks COR's popular alternatives first, then the rest of its own and neighboring categories, then every stock and fund worth at least $500 million, and shows the strongest few in each group. The full list of those with a higher return and lower volatility than COR follows the table.
Annual return is the annualized total return with dividends reinvested. Annual return, volatility and the Sharpe ratio cover 5 years; the worst decline covers the past 10 years. Green marks a better figure than COR's. "On the frontier" means no other option shown or tested earned more with less volatility. Funds that hold the same thing are shown once. Beyond the popular alternatives, nothing with more than 1.5× COR's volatility counts as better.
These figures cover the past 5 years. Green marks a better figure than COR's.
| Investment | Why it is better | Past 5 years | Downside | Long run | Fit | ||||
|---|---|---|---|---|---|---|---|---|---|
| Annual return?higher is better | Volatility?lower is calmer | Sharpe?return per unit of risk | Worst decline?past 10 years | 10Y returntotal | Corr. with COR?lower diversifies more | Expenseper year | |||
| +24.2% | 22.8% | 1.07 | −32.4% | +406% | 1.00 | — | |||
| +12.7% | 17.1% | 0.79 | −33.7% | +321% | 0.38 | 0.09% | |||
| Popular alternativesbest 4 shownThe investments people most often weigh against COR. 4 of 15 passed at least one test. | |||||||||
| On the frontierHigher return, similar volatilityHigher return in most periods | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.65 | — | ||
| Higher return in most periodsSmaller losses in recent crashes | +40.7% | 32.8% | 1.21 | −34.5% | +1,807% | 0.23 | — | ||
| Higher return, similar volatilityHigher return in most periods | +38.7% | 25.0% | 1.44 | −38.1% | +586% | 0.74 | — | ||
| Higher return in most periods | +14.1% | 30.1% | 0.59 | −54.7% | +513% | 0.62 | — | ||
| Same and neighboring categories, and shared themesbest 1 shownEverything else in Health Care Distribution and the categories next to it (Medical Devices, Managed Health Care, Health Care Services, Pharmaceuticals), plus COR's specific themes. 1 of 53 passed at least one test. | |||||||||
| Higher return in most periods | +26.1% | 23.4% | 1.11 | −45.1% | +603% | 0.24 | — | ||
| The whole marketbest 8 shownEvery other stock and fund worth at least $500 million. 68 of 3,565 passed at least one test. | |||||||||
DXJWisdomTree Japan Hedged Equity Fund · International Equity | On the frontierHigher return, lower volatilityHigher return in most periods | +26.6% | 19.1% | 1.34 | −39.1% | +428% | 0.42 | 0.48% | |
| On the frontierHigher return in most periods | +51.2% | 33.4% | 1.41 | −79.7% | +1,387% | 0.32 | — | ||
| Higher return in most periods | +18.5% | 28.0% | 0.75 | −38.5% | +1,168% | 0.12 | — | ||
| Higher return in most periods | +14.5% | 23.0% | 0.71 | −35.1% | +553% | 0.15 | 0.18% | ||
| Higher return in most periods | +33.2% | 29.4% | 1.13 | −54.9% | +483% | 0.38 | — | ||
| Higher return in most periods | +26.0% | 23.8% | 1.09 | −63.3% | +379% | 0.42 | — | ||
EPUiShares MSCI Peru and Global Exposure ETF · International | Higher return, similar volatilityHigher return in most periods | +29.5% | 24.9% | 1.17 | −51.0% | +275% | 0.37 | 0.59% | |
| Smaller losses in recent crashes | +21.3% | 25.6% | 0.89 | −30.3% | +816% | 0.42 | — | ||
What these numbers mean for COR
- Annual return
- COR returned 24.2% a year over the past 5 years with dividends reinvested, against 12.7% a year for the S&P 500. At that pace, $10,000 became about $29,500. Annual return is the steady yearly rate that would produce the same total result, so investments held over the same span compare fairly. Guide: What is performance and return? →
- Volatility
- COR's volatility over the past 5 years was 22.8%, 1.3 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, COR's return lands within 22.8% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump. Guide: Understanding and measuring risk (volatility) →
- Sharpe ratio
- COR's Sharpe ratio over the past 5 years was 1.07, against 0.79 for the S&P 500, so COR earned more for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings. Guide: Balancing reward with risk (Sharpe ratio) →
- Worst decline
- COR's worst fall from a peak to a low over the past 10 years was 32.4%, against 33.7% for the S&P 500. Losses and gains are not symmetric: climbing back from a 32.4% fall takes a 48.0% gain. Guide: Market crash risk and tail risk →
- Correlation
- Over the past 5 years, COR's monthly returns had a correlation of 0.38 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against COR instead: the lower it is, the more that option would diversify a COR holding. Guide: Correlation and diversification →
Show all 1 stock or fund worth at least $500 million that earned more than COR with less volatility
Out of 3,633 tested over 5 years. Best first; funds that hold the same thing are listed once.
| # | Investment | Found in | Annual return | Volatility | Sharpe | Worst decline | 10Y return | Corr. with COR | Expense |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DXJWisdomTree Japan Hedged Equity Fund · International Equity | Whole market | +26.6% | 19.1% | 1.34 | −39.1% | +428% | 0.42 | 0.48% |
COR against its popular alternatives
The investments people most often weigh against COR, compared period by period and year by year.
How do COR's risk and return compare with its alternatives?
This map plots each investment's annual return over the past 5 years against its volatility, the size of its typical price swings. Investments toward the upper left earned more for a smoother ride, and those toward the lower right earned less for a rougher one. The dashed lines cross at COR, which divides the map into what did better or worse on each measure.
- None of the 15 popular alternatives earned more than COR over the past 5 years with smaller price swings, so every higher return on the map came with a bumpier ride.
- 12 of the 15 popular alternatives earned less than COR over the past 5 years while swinging more, the weaker corner of the map.
- Over the past 5 years, COR returned 24.2% a year, more than the S&P 500's 12.7%, with higher volatility (22.8% against 17.1%).
Green points earned more than COR with less volatility; red points earned less with more. Hover over a point for its figures. Total returns with dividends reinvested, annualized.
All figures
| Investment | Annual return | Volatility |
|---|---|---|
| CAH Cardinal Health, Inc. | +42.1% | 24.7% |
| LLY Eli Lilly and Company | +40.7% | 32.8% |
| MCK McKesson Corporation | +38.7% | 25.0% |
| COR This pageCencora, Inc. | +24.2% | 22.8% |
| OSIS OSI Systems, Inc. | +15.5% | 34.0% |
| HCA HCA Healthcare, Inc. | +14.1% | 30.1% |
| SPY S&P 500State Street SPDR S&P 500 ETF | +12.7% | 17.1% |
| CVS CVS Health Corp. | +5.3% | 30.4% |
| OPCH Option Care Health, Inc. | +4.4% | 41.0% |
| SYY Sysco Corporation | +3.5% | 23.6% |
| CHE Chemed Corporation | +3.4% | 25.3% |
| HSIC Henry Schein, Inc. | +1.5% | 25.4% |
| UNH UnitedHealth Group Incorporated | +1.1% | 32.1% |
| LFST LifeStance Health Group, Inc. | +0.7% | 63.0% |
| WST West Pharmaceutical Services, Inc. | −1.0% | 40.7% |
| PRVA Privia Health Group, Inc. | −1.5% | 46.8% |
| PFE Pfizer Inc. | −1.7% | 25.4% |
Has COR consistently beaten its popular alternatives?
This section compares COR with the investments people most often weigh against it, checking each one over eight periods from one month to ten years. Counting how often an alternative earned more than COR helps separate lasting outperformance from a single strong stretch.
- Four of the 16 popular alternatives, led by MCK, LLY and CAH, outperformed COR in at least 3 of 5 short-term and 2 of 3 long-term timeframes.
- MCK and LLY outperformed COR in every long-term period and in all but one short-term period, the most consistent record in the group.
A green cell means the alternative earned more than COR over that period. "Qualified" marks those that did so in at least 3 of 5 short-term periods and 2 of 3 long-term periods.
| Investment | Periods outperformed | Short term | Long term | Risk · 5 years | Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Volatilitylower is calmer | Sharpehigher is better | Worst declinepast 10 years | Expense | Assets | Overlapsame sectors | ||
| COR Cencora, Inc. (this page) | — | +8.5% | +13.1% | +6.7% | +1.9% | +5.7% | +86.5% | +195% | +406% | 22.8% | 1.07 | −32.4% | — | $66B | — |
| MCK QualifiedMcKesson Corporation | 5/5 short3/3 longAll-weather | +16.2% | +24.0% | +20.2% | +25.5% | +31.3% | +131% | +413% | +586% | 25.0% | 1.44 | −38.1% | — | $120B | — |
| LLY QualifiedEli Lilly and Company | 4/5 short3/3 longAll-weather | +10.2% | +12.1% | +40.0% | +19.4% | +59.7% | +124% | +451% | +1,807% | 32.8% | 1.21 | −34.5% | — | $1.2T | — |
| CAH QualifiedCardinal Health, Inc. | 5/5 short2/3 long | +14.3% | +14.3% | +22.5% | +26.1% | +65.3% | +191% | +479% | +349% | 24.7% | 1.55 | −46.1% | — | $60B | — |
| HCA QualifiedHCA Healthcare, Inc. | 3/5 short2/3 long | +9.3% | +26.0% | −2.2% | −0.5% | +8.3% | +97.6% | +93.6% | +513% | 30.1% | 0.59 | −54.7% | — | $101B | — |
| WST Medical - Instruments & SuppliesWest Pharmaceutical Services, Inc. | 3/5 short1/3 long | +7.5% | +10.4% | +40.0% | +41.0% | +41.9% | +7.8% | −5.0% | +455% | 40.7% | 0.19 | −59.3% | — | $27B | — |
| LFST Medical - Care FacilitiesLifeStance Health Group, Inc. | 3/5 short1/3 long | −3.6% | +7.8% | +76.6% | +75.6% | +137% | +128% | +3.6% | — | 63.0% | 0.33 | −86.9% | — | $4.7B | — |
| UNH Medical - Healthcare PlansUnitedHealth Group Incorporated | 4/5 short0/3 long | +11.0% | +0.1% | +31.2% | +27.1% | +18.1% | −15.3% | +5.5% | +241% | 32.1% | 0.20 | −61.4% | — | $376B | — |
| OPCH Medical - Care FacilitiesOption Care Health, Inc. | 4/5 short0/3 long | +30.9% | +44.2% | +9.0% | −2.7% | +10.5% | −2.8% | +24.1% | +165% | 41.0% | 0.31 | −66.7% | — | $4.7B | — |
| PFE Drug Manufacturers - GeneralPfizer Inc. | 4/5 short0/3 long | +8.5% | +23.8% | +13.2% | +25.7% | +30.5% | +19.2% | −8.3% | +55.0% | 25.4% | 0.06 | −58.9% | — | $172B | — |
| BTSG Medical - Healthcare Information ServicesBrightSpring Health Services, Inc. Common Stock | 4/5 short0/3 long | +11.7% | −11.5% | +30.6% | +62.6% | +105% | — | — | — | — | — | −35.6% | — | $12B | — |
| CHE Medical - Care FacilitiesChemed Corporation | 3/5 short0/3 long | +3.3% | +0.6% | +34.1% | +22.3% | +16.6% | +2.0% | +18.1% | +273% | 25.3% | 0.26 | −42.9% | — | $6.7B | — |
| SYY Food DistributionSysco Corporation | 3/5 short0/3 long | +6.4% | +3.3% | +10.2% | +16.6% | +6.7% | +37.6% | +18.7% | +126% | 23.6% | 0.27 | −63.4% | — | $41B | — |
| CVS Medical - Healthcare PlansCVS Health Corp. | 3/5 short0/3 long | +8.2% | −11.4% | +25.6% | +21.0% | +18.5% | +52.5% | +29.2% | +47.0% | 30.4% | 0.32 | −56.8% | — | $121B | — |
| HSIC Medical - DistributionHenry Schein, Inc. | 2/5 short0/3 long | −0.6% | −1.8% | +7.0% | +10.2% | +32.5% | +24.0% | +7.9% | +41.3% | 25.4% | 0.19 | −41.4% | — | $9.4B | — |
| PRVA Medical - Healthcare Information ServicesPrivia Health Group, Inc. | 1/5 short0/3 long | +17.3% | −12.7% | −4.8% | −2.3% | −13.1% | +0.3% | −7.4% | — | 46.8% | 0.20 | −67.3% | — | $2.9B | — |
| OSIS Hardware, Equipment & PartsOSI Systems, Inc. | 0/5 short0/3 long | −2.8% | −7.4% | −37.0% | −23.8% | −23.3% | +69.6% | +106% | +194% | 34.0% | 0.59 | −53.6% | — | $3.1B | — |
How did COR do year by year?
This table shows each investment's total return in every full calendar year since 1997, along with where COR ranked among its popular alternatives each year. Annual results reveal how consistently each one kept pace with COR and how far its good and bad years diverged, detail that multiyear averages tend to smooth over.
- Ranked against its popular alternatives each year, COR finished in the top quarter in nine of 29 years and in the bottom quarter in four. In 2025, it ranked 6 of 17.
- COR finished ahead of the S&P 500 in 15 of its 29 full calendar years.
- Among its popular alternatives, OSIS came out ahead of COR most often, in 17 of the 28 years both traded.
Newest year first. Green marks a year in which the fund came out ahead of COR; gray means the two finished within a fraction of a point. The rank row places COR among the alternatives that traded the full year; dark green is the top quarter and red the bottom quarter.
| Investment | Years ahead of COR | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COR This pageCencora, Inc. | — | +51.5% | +10.4% | +25.3% | +26.3% | +38.0% | +17.0% | +18.2% | −16.6% | +20.6% | −23.3% | +16.9% | +29.9% | +65.3% | +17.9% | +10.3% | +32.4% | +48.0% | −19.8% | +3.3% | +8.9% | +41.4% | +2.5% | +5.6% | −14.5% | +25.8% | +233% | −53.3% | +11.7% | +20.8% |
| Rank among alternatives | Top quarter in 9 of 29 | 6 of 17 | 6 of 16 | 6 of 16 | 4 of 16 | 9 of 14 | 6 of 14 | 8 of 14 | 12 of 14 | 4 of 14 | 12 of 14 | 5 of 14 | 7 of 14 | 4 of 14 | 11 of 14 | 7 of 13 | 3 of 13 | 4 of 13 | 3 of 13 | 9 of 13 | 7 of 13 | 3 of 13 | 8 of 13 | 12 of 13 | 8 of 13 | 3 of 13 | 1 of 13 | 11 of 13 | 9 of 13 | 7 of 12 |
| SPY S&P 500State Street SPDR S&P 500 ETF | 14 of 29 | +17.7% | +24.9% | +26.2% | −18.2% | +28.7% | +18.3% | +31.2% | −4.6% | +21.7% | +12.0% | +1.2% | +13.5% | +32.3% | +16.0% | +1.9% | +15.1% | +26.4% | −36.8% | +5.1% | +15.9% | +4.8% | +10.7% | +28.2% | −21.6% | −11.7% | −9.8% | +20.4% | +28.7% | +33.5% |
| MCK McKesson Corporation | 14 of 29 | +44.5% | +23.7% | +24.1% | +51.8% | +44.2% | +27.1% | +26.7% | −28.4% | +12.0% | −28.3% | −4.5% | +29.3% | +67.7% | +25.6% | +11.8% | +13.8% | +62.9% | −40.4% | +29.7% | −1.2% | +64.9% | −1.4% | +19.9% | −27.2% | +4.9% | +61.2% | −71.3% | +46.9% | +96.3% |
| LLY Eli Lilly and Company | 16 of 29 | +40.3% | +33.3% | +60.9% | +34.3% | +66.1% | +31.0% | +16.2% | +40.5% | +17.8% | −10.4% | +25.4% | +39.8% | +7.3% | +24.2% | +25.2% | +3.6% | −6.2% | −21.3% | +5.7% | −5.2% | +2.6% | −17.6% | +13.1% | −17.6% | −14.4% | +41.9% | −24.3% | +29.1% | +93.6% |
| CAH Cardinal Health, Inc. | 9 of 29 | +76.3% | +19.0% | +34.1% | +54.1% | −0.4% | +10.1% | +18.0% | −24.5% | −12.7% | −17.5% | +12.6% | +23.0% | +66.0% | +3.8% | +8.1% | +21.4% | −4.4% | −39.6% | −9.8% | −5.8% | +18.7% | −4.7% | +3.5% | −8.3% | −2.5% | +108% | −36.8% | +51.7% | +29.1% |
| HCA HCA Healthcare, Inc. | 8 of 14 | +56.7% | +11.8% | +13.8% | −5.6% | +57.6% | +11.6% | +20.2% | +43.4% | +18.7% | +9.4% | −7.8% | +53.8% | +58.1% | +70.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WST West Pharmaceutical Services, Inc. | 15 of 29 | −15.7% | −6.8% | +50.0% | −49.7% | +65.9% | +89.0% | +54.1% | −0.1% | +17.0% | +41.9% | +14.0% | +9.5% | +81.3% | +46.6% | −6.4% | +7.0% | +5.5% | −5.7% | −19.8% | +108% | +1.8% | +51.2% | +43.6% | −5.2% | +11.6% | −18.4% | −11.6% | +22.4% | +7.4% |
| LFST LifeStance Health Group, Inc. | 1 of 4 | −4.5% | −5.9% | +58.5% | −48.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UNH UnitedHealth Group Incorporated | 14 of 29 | −33.1% | −2.4% | +0.8% | +6.9% | +45.2% | +21.3% | +20.0% | +14.5% | +39.8% | +38.4% | +18.3% | +36.5% | +41.0% | +8.6% | +42.2% | +19.9% | +14.8% | −54.3% | +8.3% | −13.5% | +41.2% | +51.4% | +39.4% | +18.1% | +15.3% | +131% | +23.5% | −13.4% | +10.3% |
| OPCH Option Care Health, Inc. | 9 of 29 | +37.3% | −31.1% | +12.0% | +5.8% | +81.8% | +4.8% | +4.5% | +22.7% | +180% | −40.6% | −75.0% | −5.5% | −31.3% | +97.3% | +4.4% | −37.4% | +277% | −71.3% | +123% | −54.1% | +18.6% | −9.5% | +21.2% | −67.4% | +1,934% | −64.1% | −27.8% | −28.9% | −5.0% |
| PFE Pfizer Inc. | 11 of 29 | +0.6% | −2.2% | −41.3% | −10.4% | +66.7% | +3.4% | −6.7% | +25.1% | +16.1% | +4.4% | +7.3% | +5.4% | +26.5% | +20.6% | +28.8% | +0.6% | +8.1% | −16.9% | −8.2% | +15.3% | −10.6% | −22.3% | +17.7% | −22.2% | −12.5% | +43.0% | −21.5% | +68.8% | +82.0% |
| BTSG BrightSpring Health Services, Inc. Common Stock | 1 of 1 | +120% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CHE Chemed Corporation | 15 of 29 | −18.9% | −9.1% | +14.9% | −3.2% | −0.4% | +21.6% | +55.6% | +17.0% | +52.3% | +7.9% | +42.8% | +39.1% | +12.9% | +35.4% | −18.6% | +33.6% | +21.7% | −28.4% | +51.8% | −25.1% | +48.9% | +46.9% | +32.1% | +5.7% | +2.2% | +18.9% | −8.2% | −14.1% | +20.0% |
| SYY Sysco Corporation | 10 of 29 | −1.0% | +7.4% | −1.7% | −0.3% | +8.3% | −10.4% | +39.6% | +5.5% | +12.5% | +38.8% | +5.8% | +13.4% | +18.9% | +11.9% | +3.5% | +8.0% | +26.7% | −23.5% | −13.2% | +21.0% | −17.3% | +3.7% | +26.8% | +15.6% | −11.7% | +53.5% | +45.6% | +22.1% | +41.8% |
| CVS CVS Health Corp. | 14 of 29 | +84.3% | −40.8% | −12.6% | −7.6% | +54.9% | −5.1% | +17.3% | −7.0% | −5.8% | −17.8% | +2.9% | +36.5% | +50.4% | +20.3% | +19.0% | +9.1% | +13.2% | −27.2% | +29.4% | +17.7% | +17.8% | +25.7% | +45.7% | −14.9% | −50.4% | +51.1% | −27.1% | +72.6% | +55.5% |
| HSIC Henry Schein, Inc. | 8 of 29 | +9.2% | −8.6% | −5.2% | +3.0% | +16.0% | +0.2% | +8.3% | +12.3% | −7.9% | −4.1% | +16.2% | +19.1% | +42.1% | +24.8% | +5.0% | +16.7% | +43.4% | −40.2% | +25.4% | +12.3% | +25.4% | +3.0% | +50.2% | +21.5% | +6.9% | +160% | −70.2% | +27.8% | +1.8% |
| PRVA Privia Health Group, Inc. | 0 of 4 | +21.3% | −15.1% | +1.4% | −12.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OSIS OSI Systems, Inc. | 17 of 28 | +52.3% | +29.7% | +62.3% | −14.7% | 0.0% | −7.5% | +37.4% | +13.9% | −15.4% | −14.1% | +25.3% | +33.3% | −17.1% | +31.3% | +34.2% | +33.3% | +97.0% | −47.7% | +26.5% | +13.8% | −19.0% | +18.2% | +13.1% | −6.9% | +198% | +11.5% | −36.3% | −29.5% | — |
Risk and diversification
How COR has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.
What were COR's worst declines?
A drawdown is the decline from a peak to the lowest point before a new high. This section presents COR's five deepest drawdowns since it began trading in 1995, alongside the S&P 500's return over the same dates, and how long each took to recover. Together, these figures show how much an investor could have lost and how long it took to get back to even.
- In all five of COR's worst declines, the S&P 500 held up better over the same dates.
- Not every decline was the market's doing: COR fell 70.9% from January to December 1999, while the S&P 500 rose 18.1%.
- The slowest recovery came after COR fell 38.8% from July 2015 to November 2016; it did not regain that peak until June 2020, four years later.
Green means COR fell less than the S&P 500 over the same dates. Based on daily closing prices with dividends reinvested.
| During | COR fell | S&P 500, same dates | Peak | Low | Time to the low | Back at the peak | Time to recover |
|---|---|---|---|---|---|---|---|
| No named crash | −70.9% | +18.1% | Jan 1999 | Dec 1999 | 11 months | Sep 2000 | 9 months |
| 2008 financial crisis | −49.1% | −47.5% | Apr 2007 | Nov 2008 | 19 months | Jan 2010 | 14 months |
| Dot-com bust | −43.2% | −16.9% | Jun 2002 | Mar 2003 | 9 months | Dec 2005 | 2.8 years |
| No named crash | −40.8% | −14.2% | Jul 1998 | Sep 1998 | 2 months | Jan 1999 | 4 months |
| 2015 China and oil sell-off | −38.8% | +4.0% | Jul 2015 | Nov 2016 | 16 months | Jun 2020 | 3.6 years |
How did COR do in stock market crashes?
This section measures how far COR, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000. A smaller decline means an investment held up better, and comparing results across crashes shows whether that resilience was consistent or a one-off.
- Among its popular alternatives, LLY held up best, falling less than COR in seven of the ten crashes they both traded through.
- COR fell less than the S&P 500 in six of the ten crashes it has traded through. The clearest case was the dot-com bust, when COR fell 29.7% and the S&P 500 fell 47.5%.
Newest crash first. Each figure is the fund's deepest fall within the crash window; green means a smaller fall than COR.
| Investment | Held up better | 2023 regional bank crisisMar 2023 | 2022 bear marketJan 2022 | Covid crashFeb 2020 | Late-2018 sell-offSep 2018 | February 2018 volatility shockFeb 2018 | 2015 China and oil sell-offAug 2015 | 2011 euro debt crisisJul 2011 | 2010 flash crashMay 2010 | 2008 financial crisisOct 2007 | Dot-com bustMar 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| COR This pageCencora, Inc. | — | −2.3% | −17.8% | −23.8% | −24.2% | −7.1% | −21.4% | −14.5% | −2.8% | −41.9% | −29.7% |
| SPY S&P 500State Street SPDR S&P 500 ETF | 4 of 10 | −3.4% | −24.5% | −33.7% | −19.3% | −6.5% | −12.8% | −17.9% | −1.5% | −55.2% | −47.5% |
| MCK McKesson Corporation | 4 of 10 | −0.9% | −10.5% | −32.1% | −20.7% | −6.5% | −30.8% | −14.2% | −3.5% | −57.7% | −39.4% |
| LLY Eli Lilly and Company | 7 of 10 | −0.6% | −11.7% | −16.9% | −10.2% | −8.6% | −19.6% | −10.9% | 0.0% | −50.0% | −54.3% |
| CAH Cardinal Health, Inc. | 3 of 10 | −3.5% | −21.0% | −32.1% | −25.5% | −4.6% | −15.9% | −17.5% | −1.8% | −57.9% | −36.1% |
| HCA HCA Healthcare, Inc. | 2 of 7 | −2.2% | −39.5% | −54.4% | −20.6% | −3.8% | −31.3% | −49.0% | — | — | — |
| WST West Pharmaceutical Services, Inc. | 3 of 10 | −1.6% | −44.2% | −26.2% | −24.9% | −8.5% | −14.6% | −23.1% | −1.5% | −45.1% | −41.9% |
| LFST LifeStance Health Group, Inc. | 1 of 2 | −1.6% | −52.4% | — | — | — | — | — | — | — | — |
| UNH UnitedHealth Group Incorporated | 5 of 10 | −1.8% | −16.9% | −35.9% | −18.6% | −6.7% | −12.4% | −20.7% | −0.8% | −72.4% | −19.8% |
| OPCH Option Care Health, Inc. | 2 of 10 | −5.0% | −20.0% | −65.7% | −17.2% | −3.6% | −56.6% | −25.9% | −6.0% | −85.8% | −88.7% |
| PFE Pfizer Inc. | 4 of 10 | −1.8% | −24.6% | −21.8% | −12.3% | −8.1% | −18.2% | −16.1% | −1.8% | −49.8% | −46.0% |
| CHE Chemed Corporation | 5 of 10 | −1.1% | −16.7% | −30.6% | −17.8% | −4.1% | −18.5% | −22.3% | −3.2% | −50.3% | −31.1% |
| SYY Sysco Corporation | 4 of 10 | −2.3% | −20.8% | −59.5% | −17.8% | −6.8% | −6.4% | −17.9% | −1.5% | −43.1% | −27.2% |
| CVS CVS Health Corp. | 3 of 10 | −4.4% | −19.9% | −27.3% | −22.1% | −9.2% | −16.9% | −14.2% | −1.1% | −45.3% | −62.4% |
| HSIC Henry Schein, Inc. | 5 of 10 | −1.0% | −28.5% | −41.4% | −17.7% | −4.7% | −12.8% | −18.3% | −3.0% | −47.8% | −25.6% |
| PRVA Privia Health Group, Inc. | 0 of 2 | −8.9% | −34.1% | — | — | — | — | — | — | — | — |
| OSIS OSI Systems, Inc. | 2 of 10 | −3.7% | −30.4% | −40.4% | −13.7% | −3.7% | −45.7% | −28.9% | −2.5% | −61.4% | −88.4% |
How closely does COR move with the S&P 500?
Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell. An investment that captures more of the gains than the losses has compounded ahead of the market over time. This section compares COR with its popular alternatives on both measures, and on beta (how strongly each has moved with the market), over the past 10 years.
- Over the past 10 years, COR captured 80% of the S&P 500's gains in rising months and 58% of its losses in falling months, with a beta of 0.56. That is a defensive profile: it gave up some of the market's upside in exchange for smaller losses.
- LLY took just 6% of the S&P 500's losses, against 58% for COR, while still keeping 101% of its gains.
- Four of the 13 popular alternatives had a higher capture ratio (upside capture divided by downside capture) than COR's 1.39, led by LLY, MCK and CHE.
Monthly total returns over the past 10 years, measured against SPY. 100% capture or a beta of 1.00 means moving in line with the S&P 500. Green marks a better figure than COR's: more upside, less downside or a higher capture ratio. Sorted by capture ratio.
| Investment | Upside capture | Downside capture | Capture ratio | Beta |
|---|---|---|---|---|
| COR This pageCencora, Inc. | 80% | 58% | 1.39 | 0.56 |
| LLY Eli Lilly and Company | 101% | 6% | 15.73 | 0.37 |
| MCK McKesson Corporation | 72% | 27% | 2.71 | 0.56 |
| CHE Chemed Corporation | 70% | 50% | 1.41 | 0.50 |
| CAH Cardinal Health, Inc. | 71% | 51% | 1.40 | 0.75 |
| WST West Pharmaceutical Services, Inc. | 107% | 99% | 1.09 | 1.08 |
| UNH UnitedHealth Group Incorporated | 81% | 82% | 0.98 | 0.70 |
| HCA HCA Healthcare, Inc. | 135% | 140% | 0.97 | 1.37 |
| OSIS OSI Systems, Inc. | 88% | 99% | 0.89 | 0.97 |
| SYY Sysco Corporation | 76% | 100% | 0.76 | 1.02 |
| OPCH Option Care Health, Inc. | 75% | 102% | 0.73 | 0.89 |
| PFE Pfizer Inc. | 52% | 81% | 0.65 | 0.54 |
| CVS CVS Health Corp. | 59% | 99% | 0.60 | 0.70 |
| HSIC Henry Schein, Inc. | 72% | 124% | 0.59 | 0.85 |
What diversifies COR?
Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions). This section lists large ETFs and stocks whose returns have had a low correlation with COR's. Because such investments tend not to fall at the same time, pairing COR with them can reduce a portfolio's overall swings.
- Moving a fifth of the money in COR into DXJ would have cut the portfolio's volatility by 15% over the past 5 years and raised its annual return (+21.4% for COR alone, +23.0% for the mix).
- Among large ETFs, DXJ, SMH and DBEF have moved largely independently of COR over the past 5 years, with correlations of 0.48 or lower, and each still earned a positive 5-year return.
- Among large stocks, CLS, FIX and MPC have moved largely independently of COR over the past 5 years, with correlations of 0.32 or lower, and each still earned a positive 5-year return.
Only ETFs with at least $1.0B in assets and stocks worth at least $10B, with a correlation below 0.5 over the past 5 years and a positive return, are included, ranked by Sharpe ratio; funds that hold the same thing are shown once. The year columns are the years in which COR lost money. The last two columns show a portfolio that is 80% COR and 20% the other investment, rebalanced monthly.
ETFs
| Investment | Correlation | 5Y return | Sharpe | 2018 | 2016 | 2008 | 2002 | 1999 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|
| COR Cencora, Inc. (this page) | 1.00 | +195% | 1.07 | −16.6% | −23.3% | −19.8% | −14.5% | −53.3% | 24.0% | +21.4% |
| DXJ InternationalWisdomTree Japan Hedged Equity Fund | 0.42 | +225% | 1.34 | −19.8% | +1.1% | −20.8% | — | — | 20.4% | +23.0% |
| SMH TechnologyVanEck Semiconductor ETF | 0.06 | +323% | 0.97 | −9.1% | +35.6% | −44.7% | −47.0% | — | 20.8% | +26.1% |
| DBEF InternationalXtrackers MSCI EAFE Hedged Equity ETF | 0.48 | +85.0% | 0.96 | −9.5% | +6.3% | — | — | — | 20.4% | +20.3% |
| GLD CommoditiesSPDR Gold Shares | 0.38 | +126% | 0.96 | −1.9% | +8.0% | +4.9% | — | — | 20.8% | +21.3% |
| SPMO Broad MarketInvesco S&P 500 Momentum ETF | 0.20 | +136% | 0.93 | −0.9% | +7.4% | — | — | — | 20.4% | +22.2% |
| XLE EnergyState Street Energy Select Sector SPDR ETF | 0.42 | +177% | 0.93 | −18.2% | +28.0% | −39.0% | −14.8% | +18.1% | 21.9% | +22.4% |
| FDVV Dividend & IncomeFidelity High Dividend ETF | 0.49 | +85.9% | 0.92 | −1.2% | — | — | — | — | 20.8% | +20.4% |
| VLUE Broad MarketiShares MSCI USA Value Factor ETF | 0.32 | +109% | 0.90 | −11.1% | +15.3% | — | — | — | 20.9% | +21.3% |
Stocks
| Investment | Correlation | 5Y return | Sharpe | 2018 | 2016 | 2008 | 2002 | 1999 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|
| COR Cencora, Inc. (this page) | 1.00 | +195% | 1.07 | −16.6% | −23.3% | −19.8% | −14.5% | −53.3% | 24.0% | +21.4% |
| CLS Hardware, Equipment & PartsCelestica Inc. | 0.15 | +3,143% | 1.47 | −16.3% | +7.4% | −20.5% | −65.1% | +350% | 23.9% | +39.1% |
| FIX Engineering & ConstructionComfort Systems USA, Inc. | 0.18 | +1,636% | 1.46 | +0.8% | +18.3% | −15.2% | −9.4% | −58.7% | 22.6% | +34.8% |
| MPC Oil & Gas Refining & MarketingMarathon Petroleum Corporation | 0.32 | +690% | 1.41 | −8.2% | +0.7% | — | — | — | 22.1% | +27.5% |
| HWM Aerospace & DefenseHowmet Aerospace Inc. | 0.43 | +594% | 1.36 | −37.5% | −11.5% | −67.4% | −33.1% | +133% | 23.1% | +27.5% |
| ATI Manufacturing - Metal FabricationATI Inc. | 0.26 | +1,008% | 1.34 | −9.8% | +43.9% | −70.0% | −60.8% | — | 23.5% | +30.9% |
Common questions
What was COR's worst drawdown?
COR's deepest decline since it began trading in 1995 was 70.9%, from January to December 1999. It took nine months from the low to climb back to its old high.
What were COR's best and worst years?
Over 29 full calendar years, COR's best year was 2000, when it returned 233%. Its worst was 1999, with a return of -53.3%.
Is there a better investment than COR?
Among COR's popular alternatives, CAH and MCK earned more than COR over the past 5 years with similar volatility: CAH returned 42.1% a year at 24.7% volatility, against 24.2% a year at 22.8%. Looking beyond its popular alternatives, ABBV (pharmaceuticals) was ahead of COR in most short and long periods.
Is COR more volatile than the S&P 500?
Yes. COR's volatility over the past 5 years was 22.8%, 1.3 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, COR's return lands within 22.8% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.
What is COR's Sharpe ratio?
COR's Sharpe ratio over the past 5 years was 1.07, against 0.79 for the S&P 500, so COR earned more for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.
How correlated is COR with the S&P 500?
Over the past 5 years, COR's monthly returns had a correlation of 0.38 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against COR instead: the lower it is, the more that option would diversify a COR holding.
What are the best alternatives to COR?
Of the 16 popular alternatives we compared, four outperformed COR in at least 3 of 5 short-term and 2 of 3 long-term timeframes, with dividends reinvested: MCK, LLY and CAH.
Did COR outperform the S&P 500?
COR finished ahead of the S&P 500 (SPY) in 15 of 29 full calendar years. In 2025, it returned +51.5%, against +17.7% for the index.
How did COR do in stock market crashes?
COR fell less than the S&P 500 (SPY) in six of the ten major crashes it has traded through, and further in four. The clearest case was the dot-com bust, when COR fell 29.7% and the S&P 500 fell 47.5%.
What diversifies COR?
These had a low correlation with COR over the past 5 years and still earned a positive 5-year return: among large ETFs, DXJ (correlation 0.42), SMH (correlation 0.06) and DBEF (correlation 0.48); among large stocks, CLS (correlation 0.15), FIX (correlation 0.18) and MPC (correlation 0.32). A correlation near zero means the two have moved largely independently.
How we measure
- Short-term periods are 1M, 3M, 6M, YTD, 1Y; long-term periods are 3Y, 5Y, 10Y. An investment outperformed in a period when its total return, with dividends reinvested, was higher than COR's. Returns within 0.5 points or 3% of COR's, whichever is larger, count as a tie.
- "Qualified" means outperforming in at least 3 of 5 short-term periods and 2 of 3 long-term periods. "All-weather" means outperforming in every long-term period and all but one short-term period.
- Popular alternatives are the funds and stocks most often compared with this one. We include only those that trade today, are not leveraged or inverse, and hold at least $200 million.
- Volatility is the annualized standard deviation of daily returns over 5 years, a measure of how much the price typically swings in a year. The Sharpe ratio is the return above cash for each unit of that volatility.
- A decline, or drawdown, runs from a peak to the lowest close before the next high. The worst decline ever uses all the price history we have; comparisons between funds use the past 10 years so that younger funds are judged on the same stretch.
- Sector overlap is the share of assets two funds hold in the same sectors. Correlation and the mixed-portfolio figures use monthly returns.
- Upside and downside capture follow Morningstar's definition: the compound monthly return in the months the S&P 500 rose (or fell), divided by the S&P 500's compound return in those months. Beta measures how strongly monthly returns have moved with the S&P 500. All three use the same window for every investment.
- Figures are computed from daily adjusted prices and update after each trading day. Past performance does not predict future results.
More research
Popular alternatives to COR
MCKMcKesson
LLYEli Lilly and Company
CAHCardinal Health
HCAHCA Healthcare
UNHUnitedHealth Group
PFEPfizer
SYYSysco
CVSCVS Health